Price
$6.15+8.85%Social Signal Score
Analyst Ratings
1 analystRevenue
$179.41MAnalyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Adam R. Waterous
- Sector
- Energy
- Industry
- Oil & Gas Exploration & Production
- Employees
- 197
- Beta
- 0.18
- Country
- CA
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 3.29
Financials
Revenue
$179.41M-37.9%Net Income
$53.46MEBITDA
$88.39MFree Cash Flow
$-15.15MEPS (diluted)
$0.76Shares Outstanding (diluted)
70.25M+87.3%Operating Expenses
$16.91MCash & Debt
$2.96MReturn of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $603.30M | $47.50M | $0.64 |
| 2024 | $790.95M | $121.41M | $1.76 |
| 2023 | $675.97M | $-135.67M | $-2.49 |
| 2022 | $998.85M | $131.70M | $1.92 |
| 2021 | $270.67M | $661.44M | $-0.01 |
| 2020 | $0.00 | $-360.0K | $-0.01 |
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $0.96
- Implied price
- $9.64
- Return from $5.80
- 10.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $4.79 — -17.4% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 6 | 8 | 10 | 12 | 14 |
|---|---|---|---|---|---|
| -2.0% | -9.3% | -3.9% | 0.4% | 4.2% | 7.4% |
| 3.0% | -4.7% | 1.0% | 5.6% | 9.5% | 12.9% |
| 8.0% | -0.1% | 5.9% | 10.7% | 14.8% | 18.4% |
| 13.0% | 4.6% | 10.8% | 15.8% | 20.1% | 23.9% |
| 18.0% | 9.2% | 15.7% | 20.9% | 25.4% | 29.4% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
147+166.67%Social Signal Score
Mentions (4)
- Newsnewsfilecorp.com·19d ago·Neutral
Greenfire Resources Announces Closing of Rights Offering Calgary, Alberta--(Newsfile Corp. - September 16, 2026) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company") is pleased to announce the successful completion of its previously announced C$775 million offering of rights (the "Rights") to all eligible Greenfire shareholders to purchase additional common shares of the Company (the "Common Shares") which expired at 4:00 p.m.
View source ↗ - Newsnewsfilecorp.com·20d ago·Neutral
Greenfire Resources Announces Preliminary Results for Rights Offering Calgary, Alberta--(Newsfile Corp. - September 16, 2026) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company") is pleased to announce preliminary results of its C$775 million rights offering, which expired at 4:00 p.m.
View source ↗ - Newsglobenewswire.com·49d ago·Positive
MediBeacon® Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE: VATE) (“INNOVATE”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, and an equity method investment of INNOVATE, announced that The Galien Foundation, the premier global institution dedicated to honoring innovato…
View source ↗ - Newsnewsfilecorp.com·59d ago·Neutral
Greenfire Resources Announces Terms of Upsized Rights Offering Calgary, Alberta--(Newsfile Corp. - August 7, 2026) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company") today filed a final short form prospectus (the "Final Prospectus") and a corresponding U.S. registration statement on Form F-10 (the "Registration Statement") in connection with its previously announced rights offering (the "Rights Offering").
View source ↗
Earnings
Tue, Nov 3(in 4 weeks)
Consensus estimate $0.15 per share
Typical surprise -157.1% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 5$0.31 vs $0.01beat
- Tue, May 5$-0.42 vs $0.06miss
- Thu, Mar 12$-0.08 vs $0.14miss
- Mon, Nov 3$-0.09 vs $0.14miss
- Wed, Aug 6$0.50 vs $0.23beat
Estimates and results for GFR via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by GFR officers and directors.
- Bought
- $8.3m
- Sold
- —
38 trades
0 trades
- Berding John Bbought
- Berding John Bbought
- Lindner Carl Hbought
- Lindner Carl Hbought
- Berding John Bbought
- Berding John Bbought
- Tysoe Ronald Wbought
- Lindner Carl Hbought
31 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in GFR.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.